NEW YORK (GenomeWeb) – German non-profit charitable foundation Stefan-Morsch-Stiftung today announced a collaboration with Dutch molecular diagnostics firm GenDx to increase the HLA typing resolution level of new donors in the non-profit's registry.

Stefan-Morsch-Stiftung will implement GenDx's high-resolution HLA typing method into its next-generation sequencing typing workflow as part of the deal. GexDx's approach combines its HLA typing kits with its NGSengine analysis software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.